Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.20.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2018 $ 0 $ 16 $ 104,408 $ (30) $ (88,228) $ (2) $ 16,164
Balance (in shares) at Jun. 30, 2018 12,000 16,040,000          
Sale of common stock $ 0 $ 1 1,349 0 0 0 1,350
Sale of common stock (in shares) 0 1,500,000          
Costs to raise capital $ 0 $ 0 (159) 0 0 0 (159)
Conversion of preferred stock to common stock $ 0 $ 1 (1) 0 0 0 0
Conversion of preferred stock to common stock (in shares) (1,000) 797,000          
Share-based compensation $ 0 $ 0 73 0 0 0 73
Foreign currency translation adjustment 0 0 0 (1) 0 0 (1)
Net loss 0 0 0 0 (4,398) (1) (4,399)
Balance at Sep. 30, 2018 $ 0 $ 18 105,670 (31) (92,626) (3) 13,028
Balance (in shares) at Sep. 30, 2018 11,000 18,337,000          
Balance at Jun. 30, 2018 $ 0 $ 16 104,408 (30) (88,228) (2) 16,164
Balance (in shares) at Jun. 30, 2018 12,000 16,040,000          
Issuance of notes payable under warrant exchange             0
Compensation shares             0
Deemed dividends - down round of Series A Preferred and Series B Preferred             0
Foreign currency translation adjustment             0
Net loss             (13,093)
Balance at Mar. 31, 2019 $ 0 $ 20 108,236 (31) (101,318) (5) 6,902
Balance (in shares) at Mar. 31, 2019 10,000 19,602,000          
Balance at Sep. 30, 2018 $ 0 $ 18 105,670 (31) (92,626) (3) 13,028
Balance (in shares) at Sep. 30, 2018 11,000 18,337,000          
Additional paid-in capital - capital contribution $ 0 $ 0 2,459 0 0 0 2,459
Conversion of preferred stock to common stock 0 $ 1 (1) 0 0 0 0
Conversion of preferred stock to common stock (in shares)   500,000          
Share-based compensation 0 $ 0 60 0 0 0 60
Foreign currency translation adjustment 0 0 0 1 0 0 1
Net loss 0 0 0 0 (4,469) (1) (4,470)
Balance at Dec. 31, 2018 $ 0 $ 19 108,188 (30) (97,095) (4) 11,078
Balance (in shares) at Dec. 31, 2018 11,000 18,837,000          
Conversion of preferred stock to common stock $ 0 $ 1 (1) 0 0 0 0
Conversion of preferred stock to common stock (in shares) (1,000) 623,000          
Issuance of common stock to underwriters $ 0 $ 0 0 0 0 0 0
Issuance of common stock to underwriters (in shares)   142,000          
Share-based compensation 0 $ 0 49 0 0 0 49
Foreign currency translation adjustment 0 0 0 (1) 0 0 (1)
Net loss 0 0 0 0 (4,223) (1) (4,224)
Balance at Mar. 31, 2019 $ 0 $ 20 108,236 (31) (101,318) (5) 6,902
Balance (in shares) at Mar. 31, 2019 10,000 19,602,000          
Balance at Jun. 30, 2019 $ 0 $ 20 108,295 (31) (105,821) (6) 2,457
Balance (in shares) at Jun. 30, 2019 10,000 20,152,000          
Conversion of preferred stock to common stock $ 0 $ 4 (4) 0 0 0 0
Conversion of preferred stock to common stock (in shares) (4,000) 4,000,000          
Share-based compensation $ 0 $ 0 68 0 0 0 68
Foreign currency translation adjustment 0 0 0 (1) 0 0 (1)
Net loss 0 0 0 0 (4,463) (1) (4,464)
Balance at Sep. 30, 2019 $ 0 $ 24 108,359 (32) (110,284) (7) (1,940)
Balance (in shares) at Sep. 30, 2019 6,000 24,152,000          
Balance at Jun. 30, 2019 $ 0 $ 20 108,295 (31) (105,821) (6) $ 2,457
Balance (in shares) at Jun. 30, 2019 10,000 20,152,000          
Exercise of warrants (in shares)             14,999,998
Balance at Dec. 31, 2019 $ 0 $ 55 135,071 (31) (135,606) (9) $ (520)
Balance (in shares) at Dec. 31, 2019 6,000 54,567,000          
Balance at Jun. 30, 2019 $ 0 $ 20 108,295 (31) (105,821) (6) 2,457
Balance (in shares) at Jun. 30, 2019 10,000 20,152,000          
Issuance of notes payable under warrant exchange             (3,300)
Compensation shares             $ 1
Exercise of stock options (in shares)             3,750
Deemed dividends - down round of Series A Preferred and Series B Preferred             $ 21,560
Foreign currency translation adjustment             (2)
Net loss             (12,904)
Balance at Mar. 31, 2020 $ 0 $ 107 150,774 (33) (146,882) (9) 3,957
Balance (in shares) at Mar. 31, 2020 6,000 107,360,000          
Balance at Sep. 30, 2019 $ 0 $ 24 108,359 (32) (110,284) (7) (1,940)
Balance (in shares) at Sep. 30, 2019 6,000 24,152,000          
Capital raise $ 0 $ 2 4,513 0 0 0 4,515
Capital raise (in shares) 5,000 2,450,000          
Costs to raise capital $ 0 $ 0 (60) 0 0 0 (60)
Compensation shares 0 $ 1 (1) 0 0 0 0
Compensation shares (in shares)   500,000          
Exercise of warrants 0 $ 3 688 0 0 0 691
Exercise of warrants (in shares)   3,140,000          
Deemed dividends - down round of Series A Preferred and Series B Preferred 0 $ 0 21,560 0 (21,560) 0 0
Conversion of preferred stock to common stock $ 0 $ 25 (25) 0 0 0 0
Conversion of preferred stock to common stock (in shares) (5,000) 24,325,000          
Share-based compensation $ 0 $ 0 37 0 0 0 37
Foreign currency translation adjustment 0 0 0 1 0 0 1
Net loss 0 0 0 0 (3,762) (2) (3,764)
Balance at Dec. 31, 2019 $ 0 $ 55 135,071 (31) (135,606) (9) (520)
Balance (in shares) at Dec. 31, 2019 6,000 54,567,000          
Warrant exchange $ 0 $ 15 3,285 0 (3,300) 0 0
Warrant exchange (in shares)   15,000,000          
Issuance of notes payable under warrant exchange 0 $ 0 0 0 (3,300) 0 (3,300)
Capital raise 0 $ 5 5,761 0 0 0 5,766
Capital raise (in shares)   5,000,000          
Costs to raise capital 0 $ 0 (321) 0 0 0 (321)
Compensation shares 0 $ 0 0 0 0 0 0
Compensation shares (in shares)   816,000          
Exercise of warrants 0 $ 32 6,912 0 0 0 6,944
Exercise of warrants (in shares)   31,860,000          
Exercise of stock options 0 $ 0 3 0 0 0 3
Exercise of stock options (in shares)   4,000          
Conversion of preferred stock to common stock 0 $ 0 0 0 0 0 0
Conversion of preferred stock to common stock (in shares)   113,000          
Share-based compensation 0 $ 0 63 0 0 0 63
Foreign currency translation adjustment 0 0 0 (2) 0 0  
Net loss 0 0 0 0 (4,676) 0 (4,676)
Balance at Mar. 31, 2020 $ 0 $ 107 $ 150,774 $ (33) $ (146,882) $ (9) $ 3,957
Balance (in shares) at Mar. 31, 2020 6,000 107,360,000